Trial intelligence / Profile preview

Pharmacokinetics of levobupivacaine after sciatic nerve block in children

2007-000796-42Phase 3Active

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of levobupivacaine in postoperative pain, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Pharmacokinetic characteristics of levobupivacaine after peripheral block, Perioperative and postoperative analgesic efficacy and 1 more. Started Nov 2007; status: active.

02

Drugs

levobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2007-000796-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000796-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call